Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial–mesenchymal transition

BACKGROUND: Concurrent chemoradiotherapy is the common first-line treatment for patients with advanced cervical cancer. However, radioresistance remains a major clinical challenge, which results in recurrence and poor survival. Many studies have shown the potential of Delta-like Ligand 4 (DLL4) as a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Cell Int
Main Authors: Yang, Shan-Shan, Yu, De-Yang, Du, Yu-Ting, Wang, Le, Gu, Lina, Zhang, Yun-Yan, Xiao, Min
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
Primary Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7388465/
https://ncbi.nlm.nih.gov/pubmed/32742191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01434-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍